Physician

David Russell Scott, M.D.

According to 2025 Medicare claims, David Scott, M.D. (NPI: 1093916496) practices allergy/immunology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is ALLERGY & ASTHMA CENTER OF WESTERN COLORADO P C (NPI: 1922122241; TIN: 840839115) and primary practice location at 81501-6129. Scott is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Scott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 320 traditional Medicare patients, billed 7,323 HCPCS/CPT codes, and received $100,794 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,262 prescription claims across 277 beneficiaries totaling $686,115 in drug costs, led by Nucala (Mepolizumab). 2021 DME data shows 14 claims. Open Payments data shows 1 records totaling $144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $48,892 to $100,794. In contrast, Part D prescription costs have risen steadily, from $96,098 to $686,115. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $376 and ending at $798.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	179	5,224	$48,892
2016	235	6,914	$68,676
2017	294	9,762	$95,277
2018	435	14,362	$127,362
2019	409	13,503	$126,324
2020	358	10,794	$104,397
2021	306	5,316	$69,020
2022	302	3,760	$48,016
2023	304	4,625	$53,521
2024	320	7,323	$100,794

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	153	643	$96,098
2016	191	829	$142,442
2017	205	947	$245,695
2018	234	985	$320,123
2019	248	1,151	$353,462
2020	260	1,350	$524,044
2021	249	1,308	$466,613
2022	260	1,311	$524,357
2023	227	1,136	$447,565
2024	277	1,262	$686,115

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	33	$564
2019	N/R	32	$475
2020	N/R	56	$54,367
2021	N/R	14	$370
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	64	64	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	85	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	92	96	$56
95117	Professional service for multiple injections of allergen	65	504	$9
95004	Test for allergy using allergenic extract	75	3,409	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	28	784	$183,773
Dupixent Syringe	Dupilumab	33	1,050	$143,898
Xolair	Omalizumab	25	672	$134,733
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	1,500	$31,601
Breo Ellipta	Fluticasone/Vilanterol	46	2,160	$27,274

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$144	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Russell Scott, M.D.?

Tedicare shows public-source Medicare data for David Russell Scott, M.D. (NPI 1093916496), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Russell Scott, M.D. have ACO affiliation data?

David Russell Scott, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David Russell Scott, M.D.?

David Russell Scott, M.D. is linked to ALLERGY & ASTHMA CENTER OF WESTERN COLORADO P C (billing NPI 1922122241) in the available physician profile data.

Does David Russell Scott, M.D. have Open Payments data?

David Russell Scott, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.